Table 3 Receptor conversion for ERα, PR (10% threshold) and HER2 in distant breast cancer metastases according to site
From: Receptor conversion in distant breast cancer metastases
| Â | Â | % conversion | ||
|---|---|---|---|---|
|  |  | ERα | PR | HER2 |
| Â | N | N (%) | N (%) | N(%) |
Brain | 44 | 6 (13.7) | 16 (36.3)* | 1 (2.3) |
Lung | 43 | 4 (9.4) | 8 (18.6) | 2 (4.7) |
Liver | 63 | 8 (12.7) | 26 (41.2)* | 6 (9.5) |
Skin | 76 | 5 (6.6) | 17 (22.3) | 2 (2.6) |
Gastro-intestinal | 7 | 1 (14.3) | 3 (42.9)* | 1 (14.3) |